Bottom line
XBI vs GNOM: the short answer
XBI (State Street(R) SPDR(R) S&P(R) Biotech ETF) and GNOM (Global X Genomics & Biotechnology ETF) are quite different portfolios: only about 18% of their top holdings (by weight) are shared.
But XBI is far broader, holding 161 positions to 51 for GNOM, so beyond the top names it adds exposure GNOM doesn't have.
XBI is cheaper at 0.35% vs 0.5% — a difference of $15 a year per $10,000 invested.
Over five years, XBI returned −2.7% a year vs −13.3% for GNOM.
Updated Nov 19, 2026
XBI vs GNOM side by side
| XBI | GNOM | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | SPDR (State Street) | Global X |
| Category | Technology Sector | Technology Sector |
| Expense ratio | 0.35% | 0.5% |
| Annual cost per $10k | $35 | $50 |
| 10-yr cost on $10k (prospectus) | $443 | $628 |
| Max front load | None | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +35.8% | +19.0% |
| 5-yr return (annualized) | −2.7% | −13.3% |
| 10-yr return (annualized) | +5.8% | — |
| Best quarter | +44.4% | +38.8% |
| Worst quarter | −26.2% | −24.2% |
| Net assets (fund) | $10.7B | $55.8M |
| Number of holdings | 161 | 51 |
| Portfolio turnover | 71% | 34% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | XBI | GNOM | Difference |
|---|---|---|---|
| 2025 | +35.8% | +19.0% | +16.8% |
| 2024 | +1.1% | −16.2% | +17.3% |
| 2023 | +7.5% | −8.6% | +16.1% |
| 2022 | −25.8% | −36.1% | +10.3% |
| 2021 | −20.5% | −16.0% | −4.5% |
| 2020 | +48.2% | +51.6% | −3.4% |
Source: Fund prospectus bar charts
Holdings overlap
5 of XBI's top 25 holdings also appear in GNOM's top 25.
| Holding | XBI | GNOM |
|---|---|---|
| Moderna Inc | 1.41% | 3.28% |
| Twist Bioscience Corp | 1.41% | 3.97% |
| Praxis Precision Medicines Inc | 1.29% | 4.01% |
| Natera Inc | 1.16% | 4.15% |
| Ultragenyx Pharmaceutical Inc | 1.14% | 2.25% |
Source: SEC Form N-PORT
XBI top 10
- State Street Global Advisors — 5.87%
- Apogee Therapeutics Inc — 1.49%
- Moderna Inc — 1.41%
- Twist Bioscience Corp — 1.41%
- Oruka Therapeutics Inc — 1.38%
- Kymera Therapeutics Inc — 1.36%
- Viking Therapeutics Inc — 1.30%
- Praxis Precision Medicines Inc — 1.29%
- Erasca Inc — 1.27%
- Revolution Medicines Inc — 1.20%
GNOM top 10
- Guardant Health, Inc. — 5.59%
- Illumina, Inc. — 4.82%
- Natera, Inc. — 4.15%
- Biomarin Pharmaceutical Inc. — 4.09%
- Arrowhead Pharmaceuticals, Inc. — 4.07%
- Legend Biotech Corp — 4.05%
- Praxis Precision Medicines Inc — 4.01%
- Twist Bioscience Corp — 3.97%
- Vertex Pharmaceuticals Incorporated — 3.95%
- CRISPR Therapeutics AG — 3.85%
FAQ
What is the difference between XBI and GNOM?
Which is cheaper, XBI or GNOM?
Should I own both XBI and GNOM?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.